Clinical Trial Update: Botulinum Toxin Pyloroplasty to Reduce Postoperative Nausea and Vomiting After Sleeve Gastrectomy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating botulinum toxin pyloroplasty to reduce postoperative nausea and vomiting after sleeve gastrectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bariatric Surgery-related Postoperative Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Albany Medical College | Conditions: Bariatric Surgery, Postoperative Nausea and Vomiting | Phase 4 | Status: COMPLETED